Delivery Order SPE2DB22D2108-SPE2DB25FU3BB

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,190.28, is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsule. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is January 7, 2025. The contract does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,544,046 units of Tamsulosin HCl 0.4 mg capsules. The contract has a firm fixed price of $10,292.14 and a completion date of May 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp for the supply of 1,000 units of the medication Tamsulosin Hydrochloride 0.4 mg capsules. The contract has a firm fixed price of $1,484.94 and an ultimate completion date of August 22, 2024. It is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,418,131 units of Tamsulosin HCl 0.4 mg capsules. The contract is a firm-fixed price award with a ceiling value of $7,124.76 and an ultimate completion date of August 9, 2024. AmerisourceBergen, a major pharmaceutical distributor, will provide these critical medications to support military treatment facilities and other federal healthcare programs. This order...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.85 fixed-price contract is for the delivery of 1,000 units of the prescription medication Tamsulosin HCL 0.4 mg capsules, with a completion date of December 2, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 1,000 units of the medication Tamsulosin HCl 0.4 mg capsules, with a ceiling value of $4,747.95 and a period of performance through March 26, 2024. This delivery order is issued under an...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,051.78 firm fixed price contract is for the supply of 1,000 units of the prescription medication Tamsulosin Hydrochloride 0.4 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical, which enables the agency to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1,000 units of the medication Tamsulosin Hydrochloride 0.4 mg capsules. The $4,435.02 delivery order has a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,772.00 delivery order contract is for the supply of 4,565,675,754 units of the generic drug Tamsulosin HCL 0.4 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of September 5, 2024. Amerisourcebergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 500 capsules of Tamsulosin HCl 0.4 mg. The contract has a ceiling value of $10,622.09 and is a firm fixed-price delivery order that will be completed by July 23, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December...
  • SPE2DB22D2108
    Indefinite Delivery Contract
  • SPE2DB22D2108-SPE2DB25FU3BB
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,118.38, is for the supply of 1,000 units of Tamsulosin Hydrochloride 0.4 mg capsules. The contract has an ultimate completion date of January 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is placed under that larger IDC contract. The contract does not have a set-aside designation, indicating open competition.

Generated 4/3/25, 11:00 AM